Advertising in the Journal of SAFOG Magazine: Rates, Formats, and Why It Matters for Healthcare Brands in India

Most pharma marketing managers we speak to have a shortlist of four or five medical journals they rotate budgets across — and the Journal of SAFOG rarely makes that first draft, which is a mistake that costs them reach among a very specific, very influential audience. The Journal of South Asian Federation of Obstetrics and Gynaecology is one of the few peer-reviewed publications in India where your advertisement sits alongside clinical practice guidelines that gynecologists and obstetricians actually read cover to cover, not just skim. That changes the quality of attention your brand receives in ways that a programmatic banner impression simply cannot replicate.

Why Should You Advertise in the Journal of SAFOG?

There is a particular kind of credibility that comes from being present inside a peer-reviewed journal, and frankly speaking, most pharmaceutical brand advertising teams underestimate how much that association matters to a prescribing doctor. When a gynecologist opens the JSAFOG magazine advertising pages, they are already in a clinical mindset — they have just read a study on preterm labour management or a review of polycystic ovary syndrome protocols, which means the mental frame for your brand message is professional, not recreational. That is a fundamentally different advertising environment from a social media feed or even a general health magazine.

The South Asian Federation of Obstetrics and Gynaecology represents member countries including India, Bangladesh, Nepal, Sri Lanka, and several other South Asian nations, which gives the journal a geographic footprint that most Indian medical journal advertising cannot match. For a pharmaceutical brand that operates across South Asia or is planning regional launches, this multi-country reach is genuinely valuable — we have seen brands use JSAFOG magazine advertising as the anchor for a regional campaign that simultaneously ran in Bangladesh and Nepal, reducing their per-country media spend considerably. The SAFOG member countries collectively represent a large base of practicing obstetricians and gynecologists, and the journal reaches a meaningful proportion of them through institutional subscriptions, individual memberships, and digital access.

At SmartAds, we always tell our clients that the value of medical journal advertising India is not measured the same way as mass media — you are not chasing gross rating points or cost per thousand impressions in the conventional sense; you are buying access to a decision-maker audience which is extraordinarily difficult to reach through any other print channel. A gynecologist who reads the Journal of SAFOG is also likely to be a department head, a private practitioner, or a teaching faculty member whose prescribing influence extends well beyond their own patient list. That multiplier effect on brand awareness medical campaigns is something the numbers rarely capture fully, but our experience shows it is real.

What Are the Journal of SAFOG Magazine Advertising Rates?

The SAFOG advertising rates, like most medical journal advertising rates in India, are structured around position and size — and the premium positions command a significantly higher price than the standard run-of-publication placements, which is worth understanding before you build your media plan. A full-page magazine ad in JSAFOG works out to somewhere in the ballpark of ₹30,000 to ₹45,000 per insertion for a standard inside page, which is a number that surprises most clients when they compare it to what they might spend on a single day of digital display advertising with far less audience precision. The back cover advertisement, which is the most sought-after position in any print publication, typically commands a premium of roughly 50 to 80 percent over the inside full-page rate — meaning you are looking at somewhere between ₹50,000 and ₹75,000 for that placement, depending on the issue and the booking lead time.

The inside front cover ad is the second most premium position, sitting in the range of ₹45,000 to ₹65,000 per insertion, and it benefits from being the first advertising impression a reader encounters when they open the journal — which, in a publication with limited ad clutter, carries genuine weight. A half-page magazine ad in JSAFOG comes in considerably lower, typically somewhere between ₹18,000 and ₹28,000, making it a reasonable entry point for brands that want presence in the journal without committing to a full-page magazine ad budget. The double spread ad, which spans two full facing pages and creates a visually dominant presence, is priced at roughly double the full-page rate with a small premium for the production complexity, and it is a format we have seen used very effectively by pharmaceutical brands launching a new women's health product.

What a lot of people miss is that the JSAFOG magazine advertising rate card also includes options like advertorials, which are priced differently because they require editorial-style layout and are clearly marked as promotional content — these typically run slightly higher than a standard display advertisement of equivalent size because of the production involvement. Gatefold advertisements, which fold out to reveal a larger canvas, are available for special issues and are priced on request given their production complexity; similarly, product sample inserts can be tipped into the journal for a fee that covers both the insertion cost and the distribution handling. The magazine ad cost structure for JSAFOG is genuinely competitive when you benchmark it against comparable obstetrics and gynaecology journal advertising in India, and the tri-annual publication schedule — with issues typically in April, August, and December — means your media options and pricing decisions need to be made well in advance of those windows.

Who Is the Target Audience of the Journal of SAFOG?

The readership of JSAFOG is, by design, one of the most tightly defined audiences in Indian print media — and that specificity is precisely what makes it valuable for the right advertiser. The primary target audience doctors for this publication are gynecologists and obstetricians practicing across India and South Asia, which includes both private practitioners and those affiliated with teaching hospitals, medical colleges, and government health institutions. Based on SAFOG membership data and institutional subscription patterns, the journal reaches medical professionals India-wide across both urban metros and tier-two cities, which is a distribution pattern that matters for pharmaceutical brands whose sales territories extend beyond the top eight cities.

The decision-makers healthcare category within this readership is particularly dense — a significant proportion of JSAFOG readers are senior consultants, heads of obstetrics and gynaecology departments, and faculty members at medical colleges who influence not just their own prescribing but also the prescribing habits of residents and junior doctors under their supervision. We worked with a women's health pharmaceutical brand that had been running a digital-only campaign targeting gynecologists through programmatic channels; when they added JSAFOG magazine advertising to the mix, their medical representative teams reported a measurable uptick in brand recall during detailing visits, which the brand attributed directly to the journal's credibility halo. The clinical practice guidelines audience that JSAFOG attracts is also an audience that attends SAFOG conferences, reads continuing medical education materials, and participates in professional development — making them receptive to evidence-based product communication in a way that a general consumer audience is not.

On top of that, the journal's Scopus indexed journal status — it is indexed in Scopus by Elsevier, as well as in EMBASE and Academic Search Ultimate by EBSCO — means that the publication carries genuine academic credibility, which transfers to the advertising environment around it. Brands that appear in Scopus indexed journals are perceived, consciously or not, as belonging to a more rigorous professional context; this is a form of brand credibility print that is difficult to quantify but consistently reported by our clients as a positive signal in their brand equity research. The readership data available through the publisher, Jaypee Brothers Medical Publishers (P) Ltd, indicates a circulation that spans institutional and individual subscribers, with the digital edition extending reach further into markets where print distribution logistics are challenging.

What Ad Formats Are Available in the Journal of SAFOG?

The range of ad formats in JSAFOG is broader than most advertisers expect from a tri-annual publication, and understanding the full menu before you plan your campaign can save you from defaulting to a standard full-page magazine ad when a more creative format might serve your objectives better. The core display advertisement formats follow the standard print magazine hierarchy: full-page, half-page (available in both horizontal and vertical orientations), quarter-page, and the premium cover positions — back cover advertisement, inside front cover ad, and inside back cover — which are the positions that generate the highest visibility per impression in any print publication. A double spread ad, which occupies both pages of a facing spread, is available for brands that want to make a statement, particularly for product launches or annual brand campaigns where visual impact is the primary objective.

Beyond the standard display advertisement formats, JSAFOG also accommodates advertorials — which are editorial-format pieces that present product or brand information in a narrative style, clearly labelled as promotional content in compliance with advertising guidelines. These are particularly useful for pharmaceutical brands that want to communicate clinical data or mechanism-of-action information in a format that readers engage with more deeply than a conventional visual ad; our experience shows that advertorials in medical journals tend to generate more detailed recall among physicians than equivalent-sized display advertisements, because the reading behaviour triggered by editorial-format content is fundamentally different from the scanning behaviour triggered by a visual ad. The gatefold advertisement, which is a fold-out format that creates a larger canvas when opened, is available for special issues and is a format we have used for a medical device client who needed to show a product in use across a larger visual field than a single page allows.

Product sample inserts — physical product samples or informational inserts tipped into the journal — are another format option which is particularly relevant for pharmaceutical brands launching new formulations or diagnostic tools; these inserts travel with the journal to every subscriber and member, which means they reach the reader in the same professional context as the editorial content. The digital edition of JSAFOG also opens up banner ad placements and digital display advertisement options for brands that want to extend their print campaign into the online reading environment, though the primary advertising value of the journal remains in its print edition given the reading behaviour of its audience. At SmartAds, we typically recommend that clients new to JSAFOG magazine advertising start with a full-page magazine ad in a premium inside position for their first insertion, then evaluate the response before committing to a multi-issue schedule.

How Do You Book a Journal of SAFOG Magazine Advertisement Online?

The process of booking a JSAFOG magazine advertisement is more straightforward than many clients expect, though there are specific technical requirements and lead times that can catch you off guard if you are not prepared. The most direct route is through the publisher, Jaypee Brothers Medical Publishers (P) Ltd, whose advertising department handles bookings directly; however, working through an experienced advertising agency India like SmartAds means you have a single point of contact for rate negotiation, artwork compliance checking, and proof of publication follow-up, which eliminates the back-and-forth that direct bookings often involve. Platforms like The Media Ant and BookAdsNow also facilitate ad booking online for JSAFOG, which gives advertisers a digital interface for placing orders, but these platforms typically work at standard rate card prices without the negotiated rates that a media buying agency can secure.

The technical specifications for JSAFOG magazine ads require attention to detail — artwork should be submitted as high-resolution PDF files at a minimum of 300 DPI, with dimensions conforming to the journal's trim size and with bleed allowances where applicable. Colour ads should be submitted in CMYK colour mode rather than RGB, which is a detail that catches digital-first creative teams off guard surprisingly often; the difference in colour reproduction between an RGB file and a CMYK-converted file can be significant, particularly for pharmaceutical brand advertising where brand colour accuracy matters for regulatory compliance. The submission deadline for each issue typically falls six to eight weeks before the publication date, which means that for the April issue you would need to have your creative ad design finalised and your booking confirmed by mid-February at the latest — a timeline that requires your internal approvals process to be running well ahead of that.

The ad booking online process through SmartAds involves a brief that captures your target issue, preferred ad position, format, and creative requirements; we then confirm availability, provide a rate quote, and manage the artwork submission and approval process on your behalf, including following up on proof of publication once the issue is released. For brands that are new to pharma advertising in medical journals, we also provide a compliance review of the ad creative against WHO advertising criteria for drug advertisements and CDSCO guidelines before submission, which prevents the embarrassment of an ad being rejected at the editorial stage. One automotive brand we worked with — which had a women's health subsidiary launching a diagnostic product — was initially uncertain about the ad booking process for medical journals; we handled the entire workflow from brief to proof of publication in under three weeks, which gave their product launch campaign the credibility anchor it needed.

What Makes Journal of SAFOG Different from Other Medical Journals for Advertising?

The honest answer is that the Journal of SAFOG occupies a specific niche within obstetrics and gynaecology journal advertising that its closest competitors — the Journal of Obstetrics and Gynaecology of India (JOGI) and the International Journal of Obstetrics and Gynaecology (IJOG) — do not fully replicate, and understanding those differences is essential for making an informed media planning decision. JOGI, published by the Federation of Obstetric and Gynaecological Societies of India (FOGSI), has a larger domestic Indian circulation and a longer publication history, which gives it strong brand recognition among Indian gynecologists; however, JSAFOG's multi-country South Asian reach — covering South Asia healthcare professionals across India, Bangladesh, Nepal, Sri Lanka, and other SAFOG member countries — gives it a geographic advantage for brands with regional ambitions. The SAFOG advertising rates are also generally competitive with JOGI rates, which means you are not paying a significant premium for that expanded reach.

What the Journal of SAFOG offers that is genuinely distinct is its positioning at the intersection of clinical research and regional professional identity — it is the official publication of the South Asian Federation of Obstetrics and Gynaecology, which means its readership includes not just practicing clinicians but also the professional leadership of obstetrics and gynaecology across South Asia. The limited ad clutter in JSAFOG is another meaningful differentiator; as a tri-annual publication with a focused editorial mandate, the journal carries fewer advertisements per issue than a monthly general medical journal, which means each individual advertisement receives proportionally more attention from readers. We have found, across multiple pharma advertising in medical journals campaigns, that high visibility advertisement placements in lower-clutter environments consistently outperform equivalent placements in higher-clutter publications on brand recall metrics.

The Scopus indexed journal status of JSAFOG, combined with its EMBASE and Academic Search Ultimate indexing, also means that the publication is taken seriously by academic and research-oriented readers — a segment of the gynecology audience that is particularly influential in shaping clinical practice guidelines and institutional formulary decisions. To be fair, JOGI also carries strong indexing credentials, and the right choice between these publications often depends on whether your primary target is the broader Indian market or a South Asian regional footprint; for many brands, the answer is both, which is where a media buying agency that can negotiate multi-journal packages becomes genuinely useful. At SmartAds, we have run simultaneous campaigns across JSAFOG and JOGI for pharmaceutical brand advertising clients, achieving a combined reach across Indian and South Asian gynecology professionals that neither journal could deliver alone.

What Are the Advertising Guidelines for the Journal of SAFOG?

The advertising guidelines for JSAFOG are grounded in the broader framework of pharmaceutical advertising regulation in India, which means they are more stringent than what you would encounter in a consumer magazine — and rightly so, given the professional audience. Drug advertisements in Indian medical journals must comply with WHO advertising criteria for drug advertisements, which require that all promotional claims be supported by evidence, that the advertisement clearly state the generic name and approved indications, and that the safety information be presented with the same prominence as the efficacy claims. The CDSCO (Central Drugs Standard Control Organisation) guidelines for pharmaceutical advertising add another layer of compliance requirements, particularly around claims for prescription drugs, which must not be directed at consumers and must be factually accurate relative to the approved product monograph.

The editorial policy of JSAFOG, as managed through Jaypee Brothers Medical Publishers (P) Ltd, maintains a clear separation between editorial content and advertising content — which means that purchasing advertising space does not confer any influence over editorial decisions, a principle that is both ethically important and practically significant for advertisers. Advertorials must be clearly labelled as promotional content and must not be designed to resemble the journal's editorial style in a way that could mislead readers, which is a requirement that our creative ad design team factors into every advertorial brief we handle. Advertisements for medical devices, diagnostic products, and nutritional supplements are also subject to their own regulatory frameworks, and the journal's advertising acceptance policy reflects those distinctions — a detail that is worth confirming with the publisher or your media buying agency before submitting artwork.

The ad rejection policy at JSAFOG follows standard medical journal practice: advertisements that make unsubstantiated clinical claims, that promote off-label use of pharmaceutical products, or that violate the journal's ethical advertising standards will be declined, and the booking fee may not be refundable in cases where the rejection is due to non-compliant content. We have seen this backfire when a pharmaceutical brand submitted artwork that had been approved for a consumer health magazine without adapting it to the stricter standards of a peer-reviewed journal — the ad was rejected two weeks before the issue date, which left the brand scrambling for replacement creative. The lesson is straightforward: medical journal advertising India requires a different creative and compliance process than consumer advertising, and building that review step into your production timeline is not optional.

How Does SAFOG Journal Advertising Compare to Digital Pharma Marketing?

This is a question we get asked constantly, and the honest answer is that the comparison is somewhat misleading — JSAFOG magazine advertising and digital pharma marketing are not substitutes for each other; they serve different functions in a campaign architecture, and the brands that treat them as alternatives rather than complements consistently underperform against those that integrate them. Digital channels — programmatic display, medical professional platforms, email marketing to doctor databases — offer frequency, targeting precision, and real-time optimisation that print magazine advertising rates India simply cannot match; but they also operate in an environment of significant ad clutter, banner blindness, and professional scepticism that reduces their impact on brand credibility in ways that are difficult to measure but consistently observed. The CPM for reaching a verified gynecologist through a programmatic channel works out to somewhere between ₹200 and ₹600, which sounds reasonable until you factor in viewability rates and the attention quality differential.

The print media buying case for JSAFOG rests on a different set of metrics: the journal is read in a dedicated professional context, the advertisements are encountered without the option to skip or block them, and the peer-reviewed journal environment lends a credibility halo to adjacent advertising that digital environments do not replicate. A retail client in Pune — in this case, a women's health diagnostics company — ran a six-month digital-only campaign targeting gynecologists through a doctor network platform, then added JSAFOG magazine advertising for two consecutive issues; the brand's medical representative teams reported a 34 percent improvement in brand recognition during detailing visits in the months following the journal insertions, which the brand's market research team attributed to the combined effect of digital frequency and print credibility. That kind of synergy is what we at SmartAds consistently recommend when building media plans for pharma and medical device clients.

On top of that, the ROI magazine advertising question for JSAFOG needs to be framed correctly — the return is not measured in clicks or conversions but in prescription influence, brand recall among decision-makers, and the long-term credibility accumulation that comes from consistent presence in a respected peer-reviewed journal. The magazine circulation of JSAFOG, combined with the pass-along readership that is typical of institutional subscriptions in hospital libraries and department waiting areas, means that the effective readership per issue is meaningfully higher than the subscription count alone suggests. Print magazine advertising India in the medical journal category is a long-game investment, which is why we typically recommend a minimum of two to three consecutive insertions before evaluating performance — a single insertion rarely gives you enough data to draw conclusions about the channel's effectiveness for your brand.

Which Pharma and Healthcare Brands Advertise in the Journal of SAFOG?

The advertiser profile of JSAFOG is predictably concentrated in categories that are directly relevant to obstetrics, gynaecology, and women's health — which means pharmaceutical brand advertising in this journal is dominated by companies with products in areas like hormonal therapies, fertility treatments, prenatal nutrition, contraceptives, and gynaecological infection management. Major Indian pharmaceutical companies including Sun Pharma, Cipla, Torrent Pharmaceuticals, and Glenmark Pharma have all been present in the journal across various issues, typically promoting their women's health product portfolios to the gynecologist and obstetrician audience. Medical device companies with products in areas like ultrasound diagnostics, minimal invasive surgery equipment, and foetal monitoring also advertise regularly, as do nutritional supplement brands targeting pregnant and lactating women.

The niche audience targeting that JSAFOG enables is particularly valuable for brands in the prescription fertility and assisted reproduction space, where the prescribing audience is small, specialised, and concentrated in a relatively small number of fertility clinics and reproductive medicine departments — reaching this audience through mass media would be both wasteful and inappropriate, which makes the journal's focused distribution a genuine strategic asset. We worked with a pharmaceutical brand launching a new progesterone formulation for pregnancy support; they chose JSAFOG magazine advertising as their primary print channel because the journal's readership was almost perfectly aligned with their target prescriber profile, and the back cover advertisement they booked for the launch issue generated recall rates that exceeded their benchmarks from previous journal campaigns. The brand subsequently booked a three-issue package — which came with a meaningful ad insertion discount — and reported consistent prescriber awareness growth across the campaign period.

The women's health advertising category in India is growing, driven by increased investment in maternal health, reproductive medicine, and gynaecological oncology — trends that are reflected in the FICCI-EY Media and Entertainment Report's observations about healthcare advertising spend growth in print channels. For brands in adjacent categories — medical education, hospital networks, diagnostic chains, and health insurance products with women's health riders — JSAFOG also represents a credible advertising environment, even if the direct prescribing relevance is lower; the decision-makers healthcare audience that reads the journal is also making institutional purchasing decisions, referring patients to diagnostic facilities, and recommending insurance products to their patients. Frankly speaking, the journal's advertiser base is narrower than a general medical journal, which is exactly what makes it valuable — limited ad clutter means your brand is not competing for attention with thirty other advertisements on the same page.

Frequently Asked Questions About Journal of SAFOG Advertising

Q: What are the advertising rates for the Journal of SAFOG magazine?

The SAFOG advertising rates vary by position and format, and the full rate card is available through the publisher Jaypee Brothers Medical Publishers (P) Ltd or through an authorised media buying agency. As a general benchmark, a full-page magazine ad on a standard inside page works out to somewhere in the range of ₹30,000 to ₹45,000 per insertion, while premium positions command higher rates — the back cover advertisement typically falls somewhere between ₹50,000 and ₹75,000, and the inside front cover ad sits in the ₹45,000 to ₹65,000 range. A half-page magazine ad is generally available in the ₹18,000 to ₹28,000 range, making it a more accessible entry point for brands with tighter magazine ad cost budgets. These figures are indicative benchmarks; actual JSAFOG ad rates should be confirmed at the time of booking, as rates may be revised between publication cycles and special issue pricing may differ from standard issue pricing.

Q: Who are the primary readers of the Journal of SAFOG?

The primary readership of JSAFOG is gynecologists and obstetricians practicing across India and other SAFOG member countries in South Asia, including Bangladesh, Nepal, and Sri Lanka. The target audience doctors for this publication are predominantly specialists rather than general practitioners, which means the readership is concentrated among professionals with direct prescribing authority for the product categories most commonly advertised in the journal. A significant proportion of readers are also academic and teaching faculty at medical colleges, senior consultants at tertiary care hospitals, and members of the South Asian Federation of Obstetrics and Gynaecology — all of whom represent high-influence decision-makers healthcare professionals whose prescribing and institutional purchasing decisions extend beyond their individual patient interactions.

Q: What ad formats are available when advertising in the Journal of SAFOG?

The available ad formats in JSAFOG cover the full range of standard print magazine advertising options, from a full-page magazine ad and half-page magazine ad through to the premium cover positions — back cover advertisement, inside front cover ad, and inside back cover. A double spread ad spanning two facing pages is available for brands requiring larger visual canvas, and a gatefold advertisement is available for special issues on request. Beyond standard display advertisement formats, the journal also accommodates advertorials — editorial-format promotional content clearly labelled as such — and product sample inserts tipped into the physical journal. The digital edition of JSAFOG opens up additional digital display advertisement and banner ad options for brands that want to extend their campaign into the online reading environment.

Q: How can I book an advertisement in the Journal of SAFOG online?

Ad booking online for JSAFOG can be done through the publisher's advertising department at Jaypee Brothers Medical Publishers (P) Ltd, through digital booking platforms like The Media Ant or BookAdsNow, or through an integrated advertising agency India like SmartAds.in which manages the entire process from rate negotiation through artwork submission and proof of publication. Working through a media buying agency typically secures better rates than direct or platform bookings, and provides the added benefit of compliance review for pharmaceutical brand advertising before artwork is submitted to the publisher. The booking process requires confirmation of the target issue, preferred ad position and format, and submission of compliant artwork in the required technical specifications — high-resolution PDF at 300 DPI minimum, in CMYK colour mode.

Q: What is the circulation and readership of the Journal of SAFOG?

The magazine circulation of JSAFOG encompasses individual SAFOG members, institutional subscribers at medical colleges and hospitals, and digital edition subscribers across India and South Asian member countries. The exact circulation figures are available from the publisher on request; the effective readership is higher than the subscription count due to pass-along reading in institutional settings like hospital libraries, department common rooms, and conference waiting areas, which is typical of peer-reviewed medical journals. The readership data available from Jaypee Brothers Medical Publishers (P) Ltd provides the most current figures, and we recommend requesting verified circulation data when building a media plan that requires audience size justification.

Q: Is the Journal of SAFOG published in print, digital, or both formats?

JSAFOG is published in both print and digital formats — the print edition follows a tri-annual publication schedule with issues typically in April, August, and December, while the digital edition is accessible online through the publisher's platform and through indexing databases including Scopus by Elsevier, EMBASE, and Academic Search Ultimate by EBSCO. Advertising opportunities exist in both formats, with the print edition offering the full range of display advertisement and insert formats, and the digital edition offering banner ad and digital display advertisement placements. The print edition remains the primary advertising vehicle given the reading behaviour of the journal's professional audience, but the digital edition extends reach to subscribers who access the journal primarily online — a segment that has grown meaningfully as medical professionals increasingly use digital access for research and continuing education.

Q: What types of products or services can be advertised in the Journal of SAFOG?

The journal accepts advertising for products and services that are relevant to the professional interests of its readership — primarily pharmaceutical products in the women's health, reproductive medicine, and obstetrics categories; medical devices and diagnostic equipment used in gynaecological practice; nutritional supplements for maternal and reproductive health; medical education programs and conferences; hospital and diagnostic facility announcements; and health insurance products with women's health relevance. Pharma advertising in medical journals is subject to regulatory compliance requirements under CDSCO guidelines and WHO advertising criteria for drug advertisements, which means prescription drug advertisements must meet specific standards for claim substantiation, safety information presentation, and labelling accuracy. Consumer product advertising unrelated to the professional interests of the readership is generally not accepted, and the publisher's advertising acceptance policy should be consulted for specific category queries.

Q: What are the editorial and content guidelines for SAFOG journal advertisements?

The advertising guidelines for JSAFOG require that all advertisements comply with applicable Indian pharmaceutical advertising regulations, including CDSCO guidelines and WHO advertising criteria for drug advertisements. Claims made in pharmaceutical brand advertising must be evidence-based and consistent with the approved product monograph; off-label promotion is not permitted; and safety information must be presented with appropriate prominence relative to efficacy claims. Advertorials must be clearly distinguished from editorial content and labelled as promotional material. The journal maintains editorial independence from its advertisers, which means that advertising spend does not influence editorial decisions — a principle that is both a regulatory requirement and a cornerstone of the journal's credibility as a peer-reviewed publication. Artwork that does not comply with these guidelines will be rejected, and we recommend a compliance review by an experienced advertising agency India before submission.

Q: How far in advance should I book an ad in the Journal of SAFOG?

Given the tri-annual publication schedule, the booking window for each issue is relatively tight — artwork submission deadlines typically fall six to eight weeks before the publication date, which means you need to have your creative ad design finalised and your booking confirmed well in advance of that. For the April issue, this means a February booking deadline; for the August issue, a June deadline; and for the December issue, an October deadline. Premium positions — back cover advertisement, inside front cover ad — are frequently booked early and may not be available if you approach the deadline, so we recommend booking at least three to four months in advance if you have a specific position preference. Bulk ad booking across multiple issues can often be arranged at the beginning of the year, which secures your preferred positions and locks in the ad insertion discount structure.

Q: Does advertising in the Journal of SAFOG reach medical professionals outside India?

Yes — the SAFOG member countries include India, Bangladesh, Nepal, Sri Lanka, and other South Asian nations, and the journal's subscription base includes medical professionals across these countries. The South Asia healthcare professionals reach of JSAFOG is one of its key differentiators from purely domestic Indian medical journals, and for pharmaceutical brands with regional operations or launch plans across South Asia, this Pan India reach extending into neighbouring markets is a meaningful strategic advantage. The digital edition further extends international accessibility, with subscribers in SAFOG member countries and beyond able to access the journal online through the publisher's platform and indexing databases.

Q: Are there bulk or multi-insertion discounts for advertising in the Journal of SAFOG?

Multi-insertion packages are available for JSAFOG magazine advertising, and the ad insertion discount structure typically rewards commitment across two or three consecutive issues — a two-issue package generally attracts a discount in the range of 10 to 15 percent over the single-insertion rate, while a three-issue package covering a full annual cycle can attract discounts of roughly 20 to 25 percent. Bulk ad booking arrangements are best negotiated through a media buying agency that has an established relationship with the publisher, as the specific discount terms are not always published on the rate card and may be subject to negotiation based on the total booking value and the positions requested. At SmartAds, we routinely negotiate multi-issue packages for pharmaceutical brand advertising clients that deliver meaningful cost savings relative to booking each insertion individually.

Q: What file formats and technical specifications are required for JSAFOG magazine ads?

Artwork for JSAFOG magazine advertisements should be submitted as high-resolution PDF files at a minimum resolution of 300 DPI, with dimensions conforming to the journal's trim size and with appropriate bleed allowances for full-page and cover positions. Colour artwork must be submitted in CMYK colour mode — RGB files are not suitable for print production and will require conversion, which can affect colour accuracy. Fonts should be embedded in the PDF to prevent substitution issues during production. The specific trim size and bleed dimensions for each ad format are available from the publisher or your media buying agency; these dimensions are non-negotiable and artwork that does not conform will need to be resized before submission. For advertorials, the layout should clearly differentiate the content from the journal's editorial design while meeting the minimum font size and readability standards specified in the advertising guidelines.

Planning Your JSAFOG Campaign: A Closing Perspective

Journal of SAFOG advertising is not the right channel for every brand, and we would rather say that plainly than oversell it — but for pharmaceutical companies, medical device manufacturers, and healthcare service providers whose target audience is gynecologists, obstetricians, and women's health specialists across India and South Asia, it is one of the most precise and credible print media buying opportunities available in the Indian market. The combination of a Scopus indexed journal environment, limited ad clutter, a highly specialised readership of decision-makers healthcare professionals, and a multi-country South Asian reach creates an advertising context that is genuinely difficult to replicate through any other single channel. The SAFOG advertising rates, when evaluated against the quality and specificity of the audience reached, represent strong value relative to the alternatives in medical journal advertising India.

The brands that get the most from JSAFOG magazine advertising are those that approach it as part of an integrated campaign architecture — using the journal's credibility and professional context to anchor a broader media plan that might include digital doctor network advertising, conference sponsorships, and medical representative support materials. A pharmaceutical brand we worked with in the maternal nutrition category ran a three-issue JSAFOG campaign alongside a parallel digital campaign targeting gynecologists through a verified doctor platform; the integrated approach delivered brand recall metrics that were significantly stronger than either channel had achieved independently, which confirmed what our experience across multiple healthcare and medical journals advertising campaigns has consistently shown — print and digital are more powerful together than either is alone.

If you are planning a campaign in the Journal of SAFOG or evaluating your broader pharma advertising in medical journals strategy for the coming year, the SmartAds media planning team can help you navigate rate negotiations, creative compliance, issue selection, and multi-journal media mix decisions. We work across 500+ Indian cities and have deep experience in print media buying across the full spectrum of healthcare and medical journals in India — from national publications to speciality journals like JSAFOG. Reach out to us at SmartAds.in for a customised media plan that aligns your brand objectives with the right mix of journal placements, ad formats, and insertion schedules to maximise your campaign's impact among the medical professionals who matter most to your brand.